Cargando…
Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom
Oral formulations prepared from the leaves of the kratom (Mitragyna speciosa) plant are increasingly used for their opioid-like effects to self-manage opioid withdrawal and pain. Calls to US poison centers involving kratom exposures increased >50-fold from 2011–2017, one-third of which reported c...
Autores principales: | Tanna, Rakshit S., Nguyen, James T., Hadi, Deena L., Layton, Matthew E., White, John R., Cech, Nadja B., Oberlies, Nicholas H., Rettie, Allan E., Thummel, Kenneth E., Paine, Mary F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198846/ https://www.ncbi.nlm.nih.gov/pubmed/36924284 http://dx.doi.org/10.1002/cpt.2891 |
Ejemplares similares
-
Translating Kratom-Drug Interactions: From Bedside to Bench and Back
por: Tanna, Rakshit S., et al.
Publicado: (2023) -
Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants
por: Tanna, Rakshit S., et al.
Publicado: (2022) -
An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations
por: Nguyen, James T., et al.
Publicado: (2023) -
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions
por: Todd, D. A., et al.
Publicado: (2020) -
Kratom (
Mitragyna speciosa
) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products
por: Manwill, Preston K., et al.
Publicado: (2022)